Results 251 to 260 of about 289,593 (270)

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Estrogen Receptor Signaling in the Immune System

Endocrine Reviews, 2023
Binita Chakraborty, Jovita Byemerwa
exaly  

A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer

International Journal of Molecular Sciences, 2023
François Ferriere, Gilles Flouriot, Farzad Pakdel   +2 more
exaly  

Neurofibromin Is an Estrogen Receptor-α Transcriptional Co-repressor in Breast Cancer

Cancer Cell, 2020
Ze-Yi Zheng, Meenakshi Anurag, Jonathan T Lei   +2 more
exaly  

Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer: Advances, Challenges, and Current Status

Drug Design, Development and Therapy, 2022
Fiona Zhou, Davendra Segara, Rinath M Jeselsohn   +2 more
exaly  

Therapeutic Ligands Antagonize Estrogen Receptor Function by Impairing Its Mobility

Cell, 2019
Marc Hafner, Irene P Chen, Jennifer M Giltnane   +2 more
exaly  

Ligand-dependent switching of ubiquitin–proteasome pathways for estrogen receptor

EMBO Journal, 2004
Shigeo Murata, Junn Yanagisawa
exaly  

Estrogen, Estrogen Receptor and Lung Cancer

International Journal of Molecular Sciences, 2017
Li-Han Hsu, Shu-Huei Kao
exaly  

Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy Resistance

Endocrine Reviews, 2008
Grazia Arpino, C Kent Osborne, Rachel Schiff   +2 more
exaly  

Breast Cancer, Estrogen Receptor and Ligands

Archiv Der Pharmazie, 2009
Ronald Gust
exaly